Compile Data Set for Download or QSAR
Report error Found 82 of affinity data for UniProtKB/TrEMBL: O60235
TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441788(US10640533, Table 1.35 | US10640533, Identificatio...)
Affinity DataIC50: 186nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441788(US10640533, Table 1.35 | US10640533, Identificatio...)
Affinity DataIC50: 297nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441779(US10640533, Table 1.26 | US10640533, Identificatio...)
Affinity DataIC50: 443nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441779(US10640533, Table 1.26 | US10640533, Identificatio...)
Affinity DataIC50: 455nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441789(US10640533, Table 1.36 | US10640533, Identificatio...)
Affinity DataIC50: 490nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441789(US10640533, Table 1.36 | US10640533, Identificatio...)
Affinity DataIC50: 542nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441778(US10640533, Table 1.25 | US10640533, Identificatio...)
Affinity DataIC50: 1.65E+3nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441778(US10640533, Table 1.25 | US10640533, Identificatio...)
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441781(US10640533, Table 1.28 | US10640533, Identificatio...)
Affinity DataIC50: 5.86E+3nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441776(US10640533, Table 1.23 | US10640533, Identificatio...)
Affinity DataIC50: 6.23E+3nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441780(US10640533, Table 1.27 | US10640533, Identificatio...)
Affinity DataIC50: 6.45E+3nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441776(US10640533, Table 1.23 | US10640533, Identificatio...)
Affinity DataIC50: 9.95E+3nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441781(US10640533, Table 1.28 | US10640533, Identificatio...)
Affinity DataIC50: 1.19E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441780(US10640533, Table 1.27 | US10640533, Identificatio...)
Affinity DataIC50: 1.34E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441773(US10640533, Table 1.20 | US10640533, Identificatio...)
Affinity DataIC50: 1.44E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441773(US10640533, Table 1.20 | US10640533, Identificatio...)
Affinity DataIC50: 1.53E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441790(US10640533, Table 1.37 | US10640533, Identificatio...)
Affinity DataIC50: 1.58E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441784(US10640533, Table 1.31 | US10640533, Identificatio...)
Affinity DataIC50: 1.99E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM50398607(ONX 0912 | OPROZOMIB | US10640533, Identification ...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441777(US10640533, Table 1.24 | US10640533, Identificatio...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441774(US10640533, Table 1.21 | US10640533, Identificatio...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441775(US10640533, Table 1.22 | US10640533, Identificatio...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441777(US10640533, Table 1.24 | US10640533, Identificatio...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441787(US10640533, Table 1.34 | US10640533, Identificatio...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441786(US10640533, Table 1.33 | US10640533, Identificatio...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441785(US10640533, Table 1.32 | US10640533, Identificatio...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441784(US10640533, Table 1.31 | US10640533, Identificatio...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441782(US10640533, Table 1.29 | US10640533, Identificatio...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441783(US10640533, Table 1.30 | US10640533, Identificatio...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441785(US10640533, Table 1.32 | US10640533, Identificatio...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441786(US10640533, Table 1.33 | US10640533, Identificatio...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441787(US10640533, Table 1.34 | US10640533, Identificatio...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441783(US10640533, Table 1.30 | US10640533, Identificatio...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441782(US10640533, Table 1.29 | US10640533, Identificatio...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441790(US10640533, Table 1.37 | US10640533, Identificatio...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM50398607(ONX 0912 | OPROZOMIB | US10640533, Identification ...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441774(US10640533, Table 1.21 | US10640533, Identificatio...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441775(US10640533, Table 1.22 | US10640533, Identificatio...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM50420334(CHEMBL2086421)
Affinity DataKi:  8.40nMAssay Description:Tight binding inhibition of human TMPRSS11D expressed in Drosophila melanogaster S2 cells using Boc-QAR-AMC as substrate incubated for 15 mins prior ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM50349355(CHEMBL1809213)
Affinity DataKi:  13nMAssay Description:Inhibition of human recombinant airway trypsin-like protease HAT using D-cyclohexylalanine-Pro-Arg-AMC as substrate by fluorescence plate reader anal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2012
Entry Details Article
PubMed
TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM50349344(CHEMBL1809250)
Affinity DataKi:  14nMAssay Description:Inhibition of human recombinant airway trypsin-like protease HAT using D-cyclohexylalanine-Pro-Arg-AMC as substrate by fluorescence plate reader anal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2012
Entry Details Article
PubMed
TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM50349345(CHEMBL1809251)
Affinity DataKi:  15nMAssay Description:Inhibition of human recombinant airway trypsin-like protease HAT using D-cyclohexylalanine-Pro-Arg-AMC as substrate by fluorescence plate reader anal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2012
Entry Details Article
PubMed
TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM50349333(CHEMBL1809238)
Affinity DataKi:  17nMAssay Description:Inhibition of human recombinant airway trypsin-like protease HAT using D-cyclohexylalanine-Pro-Arg-AMC as substrate by fluorescence plate reader anal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2012
Entry Details Article
PubMed
TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM50324475(CHEMBL1229259 | CHEMBL1215083 | Benzylsulfonyl-D-a...)
Affinity DataKi:  19nMAssay Description:Inhibition of human recombinant airway trypsin-like protease HAT using D-cyclohexylalanine-Pro-Arg-AMC as substrate by fluorescence plate reader anal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2012
Entry Details Article
PubMed
TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM50349346(CHEMBL1809252)
Affinity DataKi:  22nMAssay Description:Inhibition of human recombinant airway trypsin-like protease HAT using D-cyclohexylalanine-Pro-Arg-AMC as substrate by fluorescence plate reader anal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2012
Entry Details Article
PubMed
TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM50349347(CHEMBL1809253)
Affinity DataKi:  23nMAssay Description:Inhibition of human recombinant airway trypsin-like protease HAT using D-cyclohexylalanine-Pro-Arg-AMC as substrate by fluorescence plate reader anal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2012
Entry Details Article
PubMed
TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM50349348(CHEMBL1809254)
Affinity DataKi:  30nMAssay Description:Inhibition of human recombinant airway trypsin-like protease HAT using D-cyclohexylalanine-Pro-Arg-AMC as substrate by fluorescence plate reader anal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2012
Entry Details Article
PubMed
TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM50349349(CHEMBL1809255)
Affinity DataKi:  34nMAssay Description:Inhibition of human recombinant airway trypsin-like protease HAT using D-cyclohexylalanine-Pro-Arg-AMC as substrate by fluorescence plate reader anal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2012
Entry Details Article
PubMed
TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM50349350(CHEMBL1809256)
Affinity DataKi:  34nMAssay Description:Inhibition of human recombinant airway trypsin-like protease HAT using D-cyclohexylalanine-Pro-Arg-AMC as substrate by fluorescence plate reader anal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2012
Entry Details Article
PubMed
TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM50349357(CHEMBL1809214)
Affinity DataKi:  36nMAssay Description:Inhibition of human recombinant airway trypsin-like protease HAT using D-cyclohexylalanine-Pro-Arg-AMC as substrate by fluorescence plate reader anal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2012
Entry Details Article
PubMed
Displayed 1 to 50 (of 82 total ) | Next | Last >>
Jump to: